Skip to main content

Find Clinical Trials

Home
Conditions
Thromboembolism

Clinical trial condition

Thromboembolism

Explore clinical trials studying Thromboembolism. Study availability and eligibility vary by location and protocol.

219 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Thromboembolism trial results

Completed

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

NCT02111564

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +22 more
Locations: Birmingham, Alabama, United States

Mobile, Alabama, United States

Sheffield, Alabama, United States

Scottsdale, Arizona, United States

View all 593 locations

View Trial Details

Completed

App Reminder on ASA Adherence

NCT03244267

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolic Event, +2 more
Locations: Emory Orthopedic and Spine Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy

NCT02210819

Conditions: Cardiovascular Diseases, Deep Vein Thrombosis (DVT), Embolism, +9 more
Locations: Multiple Locations, Algeria

Multiple Locations, Egypt

Multiple Locations, Indonesia

Multiple Locations, Jordan

View all 21 locations

View Trial Details

Completed

Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence

NCT00486915

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Brain Diseases, +12 more
Locations: Hospital San Rafael Milan, MI, Italy

View Trial Details

Completed

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

NCT02913326

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations: HOP Pellegrin Bordeaux, France

HOP Lariboisière Paris, France

Vivantes Netzwerk für Gesundheit GmbH Berlin, Germany

Universitätsklinikum Essen AöR Essen, Germany

View all 36 locations

View Trial Details

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization

NCT01972282

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Brain Diseases, +13 more
Locations: OLV Ziekenhuis Aalst, Belgium

Hospitaux du Haut Leveque Bordeaux, France

CHU Henri Mondor Créteil, France

University Hospital Grenoble, France

View all 47 locations

View Trial Details

Completed

Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine

NCT03914053

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations: Uhmontpellier Montpellier, France

View Trial Details

Completed

A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

NCT01181167

Conditions: Cardiovascular Diseases, Embolism, Embolism and Thrombosis, +6 more
Locations: Osaka, Japan

Tokyo, Japan

View Trial Details

Completed

A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

NCT01181102

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +4 more
Locations: Osaka, Japan

Tokyo, Japan

Kaohsiung City, Taiwan

View Trial Details

Completed

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

NCT00986154

Conditions: Cardiovascular Diseases, Deep Vein Thrombosis (DVT), Embolism, +10 more
Locations: Investigational Site 7103 Mobile, Alabama, United States

Investigational Site 7132 Montgomery, Alabama, United States

Investigational Site 7126 Phoenix, Arizona, United States

Investigational Site 7139 Little Rock, Arkansas, United States

View all 454 locations

View Trial Details